Suppr超能文献

预测需要大于 7 天的VV ECMO 治疗的患者早期活动的因素:一项国际队列研究。

Predictors of early mobilization in patients requiring VV ECMO for greater than 7 days: An international cohort study.

机构信息

Division of Cardiothoracic Surgery, Department of Surgery, University of Utah Health, Salt Lake City, UT, United States of America; Department of Emergency Medicine, University of Utah Health, Salt Lake City, UT, United States of America.

Australian and New Zealand Intensive Care-Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

出版信息

Heart Lung. 2023 Nov-Dec;62:57-63. doi: 10.1016/j.hrtlng.2023.05.022. Epub 2023 Jun 12.

Abstract

BACKGROUND

Despite the demonstrated benefits of rehabilitation, active physical therapy and early mobilization are not universally performed during critical illness, especially among patients receiving extracorporeal membrane oxygenation (ECMO), with variation among sites.

OBJECTIVE

What factors are predictive of physical mobility during venovenous (VV) ECMO support?

METHODS

We performed an observational analysis of an international cohort using data from the Extracorporeal Life Support Organization (ELSO) Registry. We analyzed adults (≥18 years) supported with VV ECMO who survived for at least 7 days. Our primary outcome was early mobilization (ICU Mobility Scale score >0) at day 7 of ECMO support. Hierarchical multivariable logistic regression models were utilized to identify factors independently associated with early mobilization at day 7 of ECMO. Results are reported as adjusted odds ratios (aOR) with 95% confidence intervals (95%CI).

RESULTS

Among 8,160 unique VV ECMO patients, factors independently associated with early mobilization included cannulation for transplantation (aOR 2.86 [95% CI 2.08-3.92]; p<0.001), avoidance of mechanical ventilation (aOR 0.51 [95% CI 0.41-0.64]; p<0.0001), higher center level patient volume (6-20 patients annually: aOR 1.49 [95% CI 1 to 2.23] and >20 patients annually: aOR 2 [95% CI: 1.37 to 2.93]; p<0.0001 for group), and cannulation with a dual-lumen cannula (aOR 1.25 [95% CI 1.08-1.42]; p = 0.0018). Early mobilization was associated with a lower probability of death (29 vs 48%; p<0.0001).

CONCLUSIONS

Higher levels of early mobilization on ECMO were associated modifiable and non-modifiable patient characteristics, including cannulation with a dual-lumen cannula, and with high center level patient volume.

摘要

背景

尽管康复治疗有明显益处,但在重症患者中,积极的物理治疗和早期活动并非普遍进行,尤其是在接受体外膜肺氧合(ECMO)治疗的患者中,不同中心之间存在差异。

目的

哪些因素可预测静脉-静脉(VV)ECMO 支持期间的身体活动能力?

方法

我们利用体外生命支持组织(ELSO)登记处的数据,对国际队列进行了一项观察性分析。我们分析了至少存活 7 天的接受 VV ECMO 支持的成年(≥18 岁)患者。主要结局为 ECMO 支持第 7 天的早期活动(ICU 活动量表评分>0)。采用分层多变量逻辑回归模型,确定与 ECMO 支持第 7 天早期活动独立相关的因素。结果以调整后的优势比(aOR)和 95%置信区间(95%CI)表示。

结果

在 8160 例独特的 VV ECMO 患者中,与早期活动独立相关的因素包括为移植而置管(aOR 2.86 [95%CI 2.08-3.92];p<0.001)、避免机械通气(aOR 0.51 [95%CI 0.41-0.64];p<0.0001)、中心患者数量较高(6-20 例/年:aOR 1.49 [95%CI 1-2.23],>20 例/年:aOR 2 [95%CI:1.37-2.93];p<0.0001)和使用双腔管置管(aOR 1.25 [95%CI 1.08-1.42];p=0.0018)。早期活动与较低的死亡率相关(29% vs 48%;p<0.0001)。

结论

ECMO 期间更高水平的早期活动与可改变和不可改变的患者特征相关,包括使用双腔管置管和中心患者数量高。

相似文献

1
Predictors of early mobilization in patients requiring VV ECMO for greater than 7 days: An international cohort study.
Heart Lung. 2023 Nov-Dec;62:57-63. doi: 10.1016/j.hrtlng.2023.05.022. Epub 2023 Jun 12.
3
Characterizing the Racial Discrepancy in Hypoxemia Detection in VV-ECMO: An ELSO Registry Analysis.
Res Sq. 2023 Nov 17:rs.3.rs-3617237. doi: 10.21203/rs.3.rs-3617237/v1.
6
Dual lumen cannulation and mobilization of patients with venovenous extracorporeal membrane oxygenation.
Artif Organs. 2023 Oct;47(10):1654-1662. doi: 10.1111/aor.14604. Epub 2023 Jul 7.
7
Bicaval dual-lumen cannula for venovenous extracorporeal membrane oxygenation: Avalon© cannula in childhood disease.
Perfusion. 2015 Apr;30(3):182-6. doi: 10.1177/0267659114544714. Epub 2014 Jul 28.

引用本文的文献

2
Enhancing lung transplantation with ECMO: a comprehensive review of mechanisms, outcomes, and future considerations.
J Extra Corpor Technol. 2024 Dec;56(4):191-202. doi: 10.1051/ject/2024023. Epub 2024 Dec 20.
4
Awake venovenous extracorporeal membrane oxygenation and survival.
Front Med (Lausanne). 2024 Apr 24;11:1394698. doi: 10.3389/fmed.2024.1394698. eCollection 2024.
6
Extracorporeal Life Support Organization Registry International Report 2022: 100,000 Survivors.
ASAIO J. 2024 Feb 1;70(2):131-143. doi: 10.1097/MAT.0000000000002128. Epub 2024 Jan 5.
7
Bivalirudin-hydrogel coatings of polyvinyl chloride on extracorporeal membrane oxygenation for anticoagulation.
Front Cardiovasc Med. 2023 Dec 15;10:1301507. doi: 10.3389/fcvm.2023.1301507. eCollection 2023.
8
Survival outcomes and mobilization during venovenous extracorporeal membrane oxygenation: a retrospective cohort study.
Front Med (Lausanne). 2023 Sep 28;10:1271540. doi: 10.3389/fmed.2023.1271540. eCollection 2023.

本文引用的文献

1
Why Nature is updating its advice to authors on reporting race or ethnicity.
Nature. 2023 Apr;616(7956):219. doi: 10.1038/d41586-023-00973-7.
3
Rehabilitation of adult patients on extracorporeal membrane oxygenation: A scoping review.
Aust Crit Care. 2022 Sep;35(5):575-582. doi: 10.1016/j.aucc.2021.08.009. Epub 2021 Oct 26.
5
On the Academic Value of 30 Years of the Extracorporeal Life Support Organization Registry.
ASAIO J. 2021 Jan 1;67(1):1-3. doi: 10.1097/MAT.0000000000001318.
6
7
Extracorporeal Membrane Oxygenation for Patients With COVID-19 in Severe Respiratory Failure.
JAMA Surg. 2020 Oct 1;155(10):990-992. doi: 10.1001/jamasurg.2020.3950.
8
The Extracorporeal Life Support Organization Registry: update and perspectives.
Ann Cardiothorac Surg. 2019 Jan;8(1):93-98. doi: 10.21037/acs.2018.11.03.
9
Awake and fully mobile patients on cardiac extracorporeal life support.
Ann Cardiothorac Surg. 2019 Jan;8(1):44-53. doi: 10.21037/acs.2018.08.03.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验